Filana Therapeutics (FLNA)CEO bought ~$92K

~$92K

Approx. value · 100K sh @ $0.92

1.34M

Holds after · shares reported

Traded

Sep 30, 2026

Filed

Oct 1, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 17, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On September 17, 2026, Filana Therapeutics, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) indicating that the bid price for the Company’s common stock (the “Common Stock”), for the last thirty (30) consecutive business days, had closed below the minimum $1.00 per share and, as a result, the Company is not in compliance with the $1.00 minimum bid price…”
2. Sep 28, 2026InsiderCEO purchased ~$78K of FLNA shares in the open market
3. Sep 29, 2026InsiderCEO purchased ~$186K of FLNA shares in the open market
4. Sep 30, 2026 · this disclosureInsiderCEO purchased ~$92K of FLNA shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Filana Therapeutics

For Filana Therapeutics, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its FLNA page.

Other recent filings by Richard Barry, President & CEO

• SEC Form 4 at Filana Therapeutics (FLNA)Oct 1, 2026
• SEC Form 4 at Filana Therapeutics (FLNA)Sep 30, 2026
• SEC Form 4 at Filana Therapeutics (FLNA)Nov 24, 2025
• SEC Form 4 at Filana Therapeutics (FLNA)Nov 20, 2025
• SEC Form 4 at Filana Therapeutics (FLNA)Sep 23, 2025

The full history of Richard Barry, President & CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Filana Therapeutics

• SEC Form 4Oct 1, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Nov 25, 2025
• SEC Form 4Nov 24, 2025
• SEC Form 4Nov 20, 2025
• SEC Form 4Sep 23, 2025

Everything OQRO holds on this company is on its FLNA page.